Literature DB >> 21296590

High mobility group box 1 protein suppresses T cell-mediated immunity via CD11c(low)CD45RB(high) dendritic cell differentiation.

Qing-yang Liu1, Yong-ming Yao, Yong-hong Yan, Ning Dong, Zhi-yong Sheng.   

Abstract

AIM: High mobility group box 1 protein (HMGB1) has been identified as a late proinflammatory cytokine and plays a key role in immune regulation. However, it is not yet clear whether HMGB1 can induce the activation and differentiation of dendritic cell (DC) subsets and subsequently modulate immune function of T cells. This study was performed to investigate the effect of HMGB1 on the differentiation of splenic DCs and its influence on T cell-mediated immunity in terms of DC subsets CD11c(low)CD45RB(high) DCs and CD11c(high)CD45RB(low) DCs in male BALB/c mice spleens in vitro.
RESULTS: MACS microbeads were used to isolate splenic DCs, CD11c(low)CD45RB(high) DCs, CD11c(high)CD45RB(low) DCs and CD4(+) T cells. The percentage of CD11c(low)CD45RB(high) DCs was significantly increased after treatment with HMGB1 compared to their counterparts (CD11c(high)CD45RB(low) DCs). It was found that unlike the gradually increasing interleukin (IL)-12 secretion of CD11c(high)CD45RB(low) DCs induced by HMGB1, CD11c(low)CD45RB(high) DCs showed a obvious dose-dependent response between IL-10 production and HMGB1 stimulation. In order to verify whether the alteration of CD4(+) T cells was mainly associated with the differentiation of splenic DCs mediated by HMGB1 to CD11c(low)CD45RB(high) DCs, anti-IL-12 receptor (IL-12R) or anti-IL-10R monoclonal antibody was used to inhibit the effect of CD11c(high)CD45RB(low) DCs or CD11c(low)CD45RB(high) DCs in CD4(+) T cells mixed lymphocyte reaction culture. After treatment with anti-IL-12R or anti-IL-10 monoclonal antibody in CD4(+) T cells+CD11c(high)CD45RB(low) DCs or CD11c(low)CD45RB(high) DCs mixed lymphocyte reaction, the induction of these DCs on T cells was inhibited dramatically.
CONCLUSION: These data demonstrated that HMGB1 might induce the differentiation of splenic DCs to CD11c(low)CD45RB(high) DCs followed by shifting of Th1 to Th2 with enhancement of T lymphocyte immune function in vitro. Also, the effect of HMGB1 on T cell differentiation to Th2 was not associated with the inhibition of IL-12 production in CD11c(high)CD45RB(low) DCs.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21296590     DOI: 10.1016/j.cyto.2011.01.008

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  11 in total

1.  High Mobility Group Protein 1 Reverses Immune System Paralysis in Late-Phase Sepsis.

Authors:  Qing-Yang Liu; Yue-Xin Wang; Zong-Sheng Wu; Zhen-Wei Shi; Xu Wu; Xin Chen; Zhao Yang; Kai-Zhi Xu
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

2.  A role for HMGB1, HSP60 and Myd88 in growth of murine mammary carcinoma in vitro.

Authors:  Samantha A Chalmers; Alec S Eidelman; Jason C Ewer; Jacob M Ricca; Antonio Serrano; Kyle C Tucker; Caroline M Vail; Robert A Kurt
Journal:  Cell Immunol       Date:  2013-05-14       Impact factor: 4.868

Review 3.  Novel insights for high mobility group box 1 protein-mediated cellular immune response in sepsis: A systemic review.

Authors:  Li-Feng Huang; Yong-Ming Yao; Zhi-Yong Sheng
Journal:  World J Emerg Med       Date:  2012

Review 4.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 5.  The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases.

Authors:  Yun Ge; Man Huang; Yong-Ming Yao
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

6.  Clinical opportunities in combining immunotherapy with radiation therapy.

Authors:  Steven E Finkelstein; Mayer Fishman
Journal:  Front Oncol       Date:  2012-11-26       Impact factor: 6.244

Review 7.  Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives.

Authors:  Jing-Bo Wang; Xue Huang; Fu-Rong Li
Journal:  Cancer Commun (Lond)       Date:  2019-07-15

8.  HMGB1: The Central Cytokine for All Lymphoid Cells.

Authors:  Guanqiao Li; Xiaoyan Liang; Michael T Lotze
Journal:  Front Immunol       Date:  2013-03-20       Impact factor: 7.561

9.  HMGB1 regulates SNAI1 during NSCLC metastasis, both directly, through transcriptional activation, and indirectly, in a RSF1-IT2-dependent manner.

Authors:  Xiao-Jin Wu; Yuan-Yuan Chen; Wen-Wen Guo; Tao Li; Hai-Bei Dong; Wei Wang; Min Xie; Gao-Lei Ma; Dong-Sheng Pei
Journal:  Mol Oncol       Date:  2020-05-06       Impact factor: 6.603

10.  Astaxanthin Mitigates Thiacloprid-Induced Liver Injury and Immunotoxicity in Male Rats.

Authors:  Shimaa M Abou-Zeid; Samira H Aljuaydi; Huda O AbuBakr; Enas A Tahoun; Alessandro Di Cerbo; Mahmoud Alagawany; Samah R Khalil; Mayada R Farag
Journal:  Mar Drugs       Date:  2021-09-18       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.